NCCN Research & Business Resources
Duke Comprehensive Cancer Center
Durham, North Carolina
888.275.3853 (888.ASK.DUKE)
www.cancer.duke.edu
Learn more about clinical trials at this NCCN Member Institution.
Profile
Established in 1972 as one of the original cancer centers designated by the National Cancer Institute, Duke Comprehensive Cancer Center in Durham, North Carolina, has outstanding multidisciplinary programs for all types of cancer. In these programs, physicians, scientists, nurses, and other health care professionals representing various clinical specialties provide comprehensive, individualized treatment for patients. In 2007, Duke had more than 9,000 inpatients and 218,000 outpatient encounters including 100-120 patients who receive chemotherapy each day. Drawn by the Cancer Center's national and international reputation, more than 20 percent of these patients come from outside of North Carolina.
U.S. News & World Report has consistently ranked Duke as the top cancer center in the South. Particular strengths of the Duke Comprehensive Cancer Center include The Preston Robert Tisch Brain Tumor Center at Duke, breast and ovarian oncology, adult and pediatric stem cell transplantation (including bone marrow and cord blood transplantation), thoracic oncology (esophageal and lung cancer), and experimental therapeutics including hyperthermia and cancer vaccines. The Duke Comprehensive Cancer Center also has an outstanding Cancer Patient Support Program and Oncology Recreation Therapy Program.
Duke Comprehensive Cancer Center reaches out to the larger community through programs such as the Duke Oncology Network, a consortium of affiliated practices throughout the southeast.
The Division of Pediatric Hematology-Oncology at Duke University Medical Center offers a comprehensive range of medical services for children, adolescents, and young adults. Coordinated teams of physicians, nurses, nurse practitioners, physician assistants, psychologists, social workers, and others care for each patient in modern facilities, offering the latest advances in clinical care. Patients also can participate in both national and Duke-led clinical research studies testing new treatments. Special expertise is available in stem cell (bone marrow and cord blood) transplantation, sickle cell disease, auto-immune blood disorders, myelodysplastic syndromes, inherited blood diseases, hemangiomas and vascular malformations, and long-term follow-up for survivors of childhood cancer.
The Hereditary Cancer Clinic at Duke Comprehensive Cancer Center, a member of the National Cancer Institute's Cancer Genetics Network, offers cancer risk assessment and education to cancer patients and people with a family history of cancer or other cancer risk factors. Duke's board-certified genetic counselor teams with medical oncologists to inform interested patients about their cancer risk, early detection, risk-reduction, and genetic testing. Through the Hereditary Cancer Clinic, individuals may be able to participate in research projects aimed at understanding and identifying the inherited genes that are important in cancer.
E-mail
Print
Mark
